Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Viral Vector Development Service Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Retroviral Vectors
1.2.3 Lentiviral Vectors
1.2.4 Adenoviral Vectors
1.2.5 Adeno-associated Viral Vectors
1.2.6 Others Viral Vectors
1.3 Market by Application
1.3.1 Global Viral Vector Development Service Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Pharmaceutical Manufacturers
1.3.3 Biotechnology Companies
1.3.4 Research Institutes
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Viral Vector Development Service Market Perspective (2019-2030)
2.2 Viral Vector Development Service Growth Trends by Region
2.2.1 Global Viral Vector Development Service Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Viral Vector Development Service Historic Market Size by Region (2019-2024)
2.2.3 Viral Vector Development Service Forecasted Market Size by Region (2025-2030)
2.3 Viral Vector Development Service Market Dynamics
2.3.1 Viral Vector Development Service Industry Trends
2.3.2 Viral Vector Development Service Market Drivers
2.3.3 Viral Vector Development Service Market Challenges
2.3.4 Viral Vector Development Service Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Viral Vector Development Service Players by Revenue
3.1.1 Global Top Viral Vector Development Service Players by Revenue (2019-2024)
3.1.2 Global Viral Vector Development Service Revenue Market Share by Players (2019-2024)
3.2 Global Viral Vector Development Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Viral Vector Development Service Revenue
3.4 Global Viral Vector Development Service Market Concentration Ratio
3.4.1 Global Viral Vector Development Service Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Viral Vector Development Service Revenue in 2023
3.5 Viral Vector Development Service Key Players Head office and Area Served
3.6 Key Players Viral Vector Development Service Product Solution and Service
3.7 Date of Enter into Viral Vector Development Service Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Viral Vector Development Service Breakdown Data by Type
4.1 Global Viral Vector Development Service Historic Market Size by Type (2019-2024)
4.2 Global Viral Vector Development Service Forecasted Market Size by Type (2025-2030)
5 Viral Vector Development Service Breakdown Data by Application
5.1 Global Viral Vector Development Service Historic Market Size by Application (2019-2024)
5.2 Global Viral Vector Development Service Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Viral Vector Development Service Market Size (2019-2030)
6.2 North America Viral Vector Development Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Viral Vector Development Service Market Size by Country (2019-2024)
6.4 North America Viral Vector Development Service Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Viral Vector Development Service Market Size (2019-2030)
7.2 Europe Viral Vector Development Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Viral Vector Development Service Market Size by Country (2019-2024)
7.4 Europe Viral Vector Development Service Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Viral Vector Development Service Market Size (2019-2030)
8.2 Asia-Pacific Viral Vector Development Service Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Viral Vector Development Service Market Size by Region (2019-2024)
8.4 Asia-Pacific Viral Vector Development Service Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Viral Vector Development Service Market Size (2019-2030)
9.2 Latin America Viral Vector Development Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Viral Vector Development Service Market Size by Country (2019-2024)
9.4 Latin America Viral Vector Development Service Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Viral Vector Development Service Market Size (2019-2030)
10.2 Middle East & Africa Viral Vector Development Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Viral Vector Development Service Market Size by Country (2019-2024)
10.4 Middle East & Africa Viral Vector Development Service Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 UJIFILM Diosynth Biotechnologies
11.1.1 UJIFILM Diosynth Biotechnologies Company Detail
11.1.2 UJIFILM Diosynth Biotechnologies Business Overview
11.1.3 UJIFILM Diosynth Biotechnologies Viral Vector Development Service Introduction
11.1.4 UJIFILM Diosynth Biotechnologies Revenue in Viral Vector Development Service Business (2019-2024)
11.1.5 UJIFILM Diosynth Biotechnologies Recent Development
11.2 Sanofi
11.2.1 Sanofi Company Detail
11.2.2 Sanofi Business Overview
11.2.3 Sanofi Viral Vector Development Service Introduction
11.2.4 Sanofi Revenue in Viral Vector Development Service Business (2019-2024)
11.2.5 Sanofi Recent Development
11.3 Spark Therapeutics
11.3.1 Spark Therapeutics Company Detail
11.3.2 Spark Therapeutics Business Overview
11.3.3 Spark Therapeutics Viral Vector Development Service Introduction
11.3.4 Spark Therapeutics Revenue in Viral Vector Development Service Business (2019-2024)
11.3.5 Spark Therapeutics Recent Development
11.4 UniQure
11.4.1 UniQure Company Detail
11.4.2 UniQure Business Overview
11.4.3 UniQure Viral Vector Development Service Introduction
11.4.4 UniQure Revenue in Viral Vector Development Service Business (2019-2024)
11.4.5 UniQure Recent Development
11.5 MassBiologics
11.5.1 MassBiologics Company Detail
11.5.2 MassBiologics Business Overview
11.5.3 MassBiologics Viral Vector Development Service Introduction
11.5.4 MassBiologics Revenue in Viral Vector Development Service Business (2019-2024)
11.5.5 MassBiologics Recent Development
11.6 FinVector
11.6.1 FinVector Company Detail
11.6.2 FinVector Business Overview
11.6.3 FinVector Viral Vector Development Service Introduction
11.6.4 FinVector Revenue in Viral Vector Development Service Business (2019-2024)
11.6.5 FinVector Recent Development
11.7 Thermo Fisher Scientific (Brammer Bio)
11.7.1 Thermo Fisher Scientific (Brammer Bio) Company Detail
11.7.2 Thermo Fisher Scientific (Brammer Bio) Business Overview
11.7.3 Thermo Fisher Scientific (Brammer Bio) Viral Vector Development Service Introduction
11.7.4 Thermo Fisher Scientific (Brammer Bio) Revenue in Viral Vector Development Service Business (2019-2024)
11.7.5 Thermo Fisher Scientific (Brammer Bio) Recent Development
11.8 Cell and Gene Therapy Catapult
11.8.1 Cell and Gene Therapy Catapult Company Detail
11.8.2 Cell and Gene Therapy Catapult Business Overview
11.8.3 Cell and Gene Therapy Catapult Viral Vector Development Service Introduction
11.8.4 Cell and Gene Therapy Catapult Revenue in Viral Vector Development Service Business (2019-2024)
11.8.5 Cell and Gene Therapy Catapult Recent Development
11.9 Cobra Biologics
11.9.1 Cobra Biologics Company Detail
11.9.2 Cobra Biologics Business Overview
11.9.3 Cobra Biologics Viral Vector Development Service Introduction
11.9.4 Cobra Biologics Revenue in Viral Vector Development Service Business (2019-2024)
11.9.5 Cobra Biologics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details